Bajin Wei
Impact in
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
-
- Cancer, Lipids, and Metabolism
Papers in
-
- Ubiquitin and proteasome pathways 5
- RNA modifications and cancer 5
- Circular RNAs in diseases 2
- Oncology 9
- Cancer-related Molecular Pathways 3
- Co-authors
- Chunyang Xing (6 shared papers)Minya Yao (3 shared papers)Peifen Fu (2 shared papers)Yu Liu (2 shared papers)Yujiao Deng (10 shared papers)Shuqian Wang (5 shared papers)Yi Zheng (8 shared papers)Shusen Zheng (11 shared papers)
- Journals
- Frontiers in Oncology (4 papers)Journal of Translational Medicine (2 papers)OncoTargets and Therapy (2 papers)Frontiers in Pharmacology (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- ChinaMadagascarUnited States
In The Last Decade
Bajin Wei
32 papers receiving 881 citations
Peers
Comparison fields: 5 of 81
- Oncology 298
- Cancer Research 137
- Cell Biology 89
- Molecular Biology 274
- Immunology 75
Countries citing papers authored by Bajin Wei
This map shows the geographic impact of Bajin Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bajin Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bajin Wei more than expected).
Fields of papers citing papers by Bajin Wei
This network shows the impact of papers produced by Bajin Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bajin Wei. The network helps show where Bajin Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Bajin Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 150 | |
| 2 | 2016 | 120 | |
| 3 | 2022 | 79 | |
| 4 | 2014 | 76 | |
| 5 | 2021 | 51 | |
| 6 | 2012 | 45 | |
| 7 | 2012 | 41 | |
| 8 | 2022 | 38 | |
| 9 | 2018 | 38 | |
| 10 | 2021 | 25 | |
| 11 | 2012 | 23 | |
| 12 | 2020 | 23 | |
| 13 | 2021 | 22 | |
| 14 | 2020 | 22 | |
| 15 | 2024 | 16 | |
| 16 | Tracheal, bronchus, and lung cancer burden and related risk factors in the United States and China. | 2021 | 16 |
| 17 | 2021 | 13 | |
| 18 | 2013 | 12 | |
| 19 | 2013 | 11 | |
| 20 | 2021 | 11 |
About Bajin Wei
Bajin Wei is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 32 papers that have together received 884 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (5 papers), RNA modifications and cancer (5 papers), MicroRNA in disease regulation (4 papers), Cancer-related Molecular Pathways (3 papers), Cancer-related molecular mechanisms research (3 papers), Ferroptosis and cancer prognosis (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Oncology (298 citations), Cancer Research (137 citations), Cell Biology (89 citations), Molecular Biology (274 citations) and Immunology (75 citations). Bajin Wei has collaborated with scholars based in China, Madagascar and United States. Frequent co-authors include Chunyang Xing, Minya Yao, Peifen Fu, Yu Liu, Yujiao Deng, Shuqian Wang, Yi Zheng, Shusen Zheng, Haiyang Xie and Lin Zhou. Their work appears in journals such as Frontiers in Oncology, Journal of Translational Medicine, OncoTargets and Therapy, Frontiers in Pharmacology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.